Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin

Filipe Elvas; Christel Vangestel; Koon Pak; Peter Vermeulen; Brian Gray; Sigrid Stroobants; Steven Staelens; Leonie Wyffels

doi:10.2967/jnumed.115.168344

Research ArticleBasic Science Investigations

Early Prediction of Tumor Response to Treatment: Preclinical Validation of ^99mTc-Duramycin

Filipe Elvas, Christel Vangestel, Koon Pak, Peter Vermeulen, Brian Gray, Sigrid Stroobants, Steven Staelens and Leonie Wyffels

Journal of Nuclear Medicine May 2016, 57 (5) 805-811; DOI: https://doi.org/10.2967/jnumed.115.168344

Filipe Elvas

1Molecular Imaging Center Antwerp, University of Antwerp, Wilrijk, Belgium

2Department of Nuclear Medicine, University Hospital Antwerp, Edegem, Belgium

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christel Vangestel

1Molecular Imaging Center Antwerp, University of Antwerp, Wilrijk, Belgium

2Department of Nuclear Medicine, University Hospital Antwerp, Edegem, Belgium

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Koon Pak

3Molecular Targeting Technologies, Inc., West Chester, Pennsylvania; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Peter Vermeulen

4Laboratory of Pathology, General Hospital Sint-Augustinus, Antwerp, Belgium

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Brian Gray

3Molecular Targeting Technologies, Inc., West Chester, Pennsylvania; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sigrid Stroobants

1Molecular Imaging Center Antwerp, University of Antwerp, Wilrijk, Belgium

2Department of Nuclear Medicine, University Hospital Antwerp, Edegem, Belgium

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Steven Staelens

1Molecular Imaging Center Antwerp, University of Antwerp, Wilrijk, Belgium

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Leonie Wyffels

1Molecular Imaging Center Antwerp, University of Antwerp, Wilrijk, Belgium

2Department of Nuclear Medicine, University Hospital Antwerp, Edegem, Belgium

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 57, Issue 5

May 1, 2016

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Early Prediction of Tumor Response to Treatment: Preclinical Validation of ^99mTc-Duramycin

Filipe Elvas, Christel Vangestel, Koon Pak, Peter Vermeulen, Brian Gray, Sigrid Stroobants, Steven Staelens, Leonie Wyffels

Journal of Nuclear Medicine May 2016, 57 (5) 805-811; DOI: 10.2967/jnumed.115.168344

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Early Prediction of Tumor Response to Treatment: Preclinical Validation of ^99mTc-Duramycin

Filipe Elvas, Christel Vangestel, Koon Pak, Peter Vermeulen, Brian Gray, Sigrid Stroobants, Steven Staelens, Leonie Wyffels

Journal of Nuclear Medicine May 2016, 57 (5) 805-811; DOI: 10.2967/jnumed.115.168344

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Molecular Imaging of Apoptosis in Atherosclerosis by Targeting Cell Membrane Phospholipid Asymmetry
Noninvasive Whole-Body Imaging of Phosphatidylethanolamine as a Cell Death Marker Using 99mTc-Duramycin During TNF-Induced SIRS
99mTc-Duramycin SPECT Imaging of Early Tumor Response to Targeted Therapy: A Comparison with 18F-FDG PET

Google Scholar

Keywords

cell death
99mTc-duramycin
SPECT imaging
chemotherapy
radiotherapy

Main menu

User menu

Search

Early Prediction of Tumor Response to Treatment: Preclinical Validation of ^99mTc-Duramycin

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords